A detailed history of Summit Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Summit Asset Management, LLC holds 1,328 shares of LLY stock, worth $1.21 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,328
Previous 1,357 2.14%
Holding current value
$1.21 Million
Previous $791,000 30.59%
% of portfolio
0.12%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$592.2 - $792.28 $17,173 - $22,976
-29 Reduced 2.14%
1,328 $1.03 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $22,057 - $26,003
-42 Reduced 3.0%
1,357 $791,000
Q3 2023

Nov 06, 2023

SELL
$434.7 - $599.3 $8,694 - $11,986
-20 Reduced 1.41%
1,399 $751,000
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $14,731 - $19,697
-42 Reduced 2.87%
1,419 $665,000
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $47,267 - $55,076
-147 Reduced 9.14%
1,461 $534,000
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $44,472 - $50,680
150 Added 10.29%
1,608 $520,000
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $4,180 - $4,909
15 Added 1.04%
1,458 $473,000
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $10,561 - $13,124
-45 Reduced 3.02%
1,443 $413,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $13,940 - $17,300
62 Added 4.35%
1,488 $411,000
Q3 2021

Nov 08, 2021

BUY
$221.6 - $272.71 $66,480 - $81,813
300 Added 26.64%
1,426 $329,000
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $185,024 - $239,522
1,126 New
1,126 $210,000
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $177,816 - $235,294
-1,363 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$146.22 - $169.13 $199,297 - $230,524
1,363 New
1,363 $202,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Summit Asset Management, LLC Portfolio

Follow Summit Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Asset Management, LLC with notifications on news.